Publikationen, an denen er mitarbeitet FRANCISCO JAVIER MICHEL DE LA ROSA (1)

2023

  1. First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma

    Journal of Investigational Allergology and Clinical Immunology